Henry Schein (NASDAQ:HSIC) Cut to Sell at StockNews.com

Henry Schein (NASDAQ:HSIC) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a report released on Wednesday.

A number of other brokerages have also commented on HSIC. Evercore ISI upped their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Friday, September 20th. Robert W. Baird dropped their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. decreased their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $77.50.

Henry Schein Stock Performance

NASDAQ:HSIC traded up $0.26 during trading hours on Wednesday, hitting $70.64. 1,797,212 shares of the company traded hands, compared to its average volume of 1,332,847. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. Henry Schein has a twelve month low of $60.01 and a twelve month high of $82.63. The firm has a 50-day moving average of $70.62 and a 200 day moving average of $69.78. The stock has a market capitalization of $9.05 billion, a price-to-earnings ratio of 23.86, a P/E/G ratio of 2.00 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. During the same quarter last year, the company earned $1.31 earnings per share. The firm’s revenue was up .0% on a year-over-year basis. On average, analysts forecast that Henry Schein will post 4.74 EPS for the current year.

Insider Transactions at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.14% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

Hedge funds and other institutional investors have recently made changes to their positions in the company. Private Management Group Inc. bought a new position in shares of Henry Schein in the 3rd quarter valued at about $24,176,000. Farther Finance Advisors LLC increased its stake in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after acquiring an additional 346 shares during the last quarter. Stephens Investment Management Group LLC raised its position in shares of Henry Schein by 8.9% in the 3rd quarter. Stephens Investment Management Group LLC now owns 179,716 shares of the company’s stock valued at $13,101,000 after acquiring an additional 14,631 shares during the period. Deroy & Devereaux Private Investment Counsel Inc. grew its holdings in Henry Schein by 0.7% during the third quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 47,055 shares of the company’s stock valued at $3,430,000 after purchasing an additional 325 shares during the period. Finally, DekaBank Deutsche Girozentrale increased its stake in Henry Schein by 13.1% in the third quarter. DekaBank Deutsche Girozentrale now owns 953,792 shares of the company’s stock valued at $69,498,000 after purchasing an additional 110,270 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.